Deprecated: Creation of dynamic property Yoast\WP\SEO\Premium\Generated\Cached_Container::$normalizedIds is deprecated in /home1/ziiemgmy/public_html/website_47fbb026/wp-content/plugins/wordpress-seo-premium/src/generated/container.php on line 27
Hematologic Cancers Archives - Page 3 of 12 - Together4Cancer Compass
Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

From pretraining to privacy: federated ultrasound foundation model with self-supervised learning.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study introduces UltraFedFM, a privacy-preserving ultrasound foundation model developed via federated learning acro...

Continue ReadingFrom pretraining to privacy: federated ultrasound foundation model with self-supervised learning.

JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This publication reviews the current landscape of JAK inhibitors in the treatment of myelofibrosis, a myeloproliferative...

Continue ReadingJAK inhibitor selection in challenging scenarios of myelofibrosis: a review.

Radiotherapy alone versus combined therapy in stage I natural killer/T-cell lymphoma: impact of local invasion on treatment outcomes.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This retrospective study analyzed 294 stage I natural killer/T-cell lymphoma (NKTCL) patients treated with radiation the...

Continue ReadingRadiotherapy alone versus combined therapy in stage I natural killer/T-cell lymphoma: impact of local invasion on treatment outcomes.

Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This scoping review systematically examined the safety and feasibility of combining immune checkpoint inhibitors (ICIs)...

Continue ReadingCombining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

An Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study addresses a key limitation in CRISPR/Cas9 gene knockout research within cancer immunology, where persistent e...

Continue ReadingAn Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.

A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This retrospective cohort study of 6,526 adult cancer patients treated with immune checkpoint inhibitors (ICIs) between...

Continue ReadingA real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use